Investor Relations

Zosano Pharma is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy, but altering their delivery profile using the Company’s proprietary transdermal delivery system. The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action.

NASDAQ: ZSAN
0.47
+ 0.00 (+0.77%)
Day High: 0.49
Day Low:  0.44
Volume:    1,132,461
3:59 PM ET on Jan 23, 2018

Delayed at least 20 minutes.